Molecular Diagnostics
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Barrett's esophagus is the sole precursor known and is a significant risk factor for the development of esophageal cancer. It is crucial to identify patients with Barrett's esophagus who will go on to develop high-grade dysplasia or esophageal cancer in the future. Now, a new test can meet this important unmet medical need by enabling accurate prognosis and detection data for individuals who may be susceptible to esophageal cancer. More...23 Mar 2023
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
A handheld portable immunoanalyzer with the sensitivity and precision of centralized laboratory equipment is currently being developed in a form factor suitable for low-cost, point-of-care testing anywhere in the world. More...22 Mar 2023
Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting 
An automated point of care MDx system enables rapid, effortless and accurate molecular diagnostic testing of infectious diseases, drug resistance, and genetic testing from human specimens. More...
22 Mar 2023
Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer
Even if pancreatic cancer is detected in its early stages, it usually spreads cells throughout the body, leading to an elevated risk of recurrence. Now, researchers have discovered a set of biomarkers that may help understand whether cysts on the pancreas are likely to remain benign or develop into cancer. More...20 Mar 2023
Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection
Leading multiple sclerosis (MS) experts are recommending genetic testing to identify MS patients with an increased likelihood of experiencing serious medication side effects, particularly a fatal brain infection called progressive multifocal leukoencephalopathy (PML). More...20 Mar 2023
Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics
Pancreatic cancer is the third deadliest cancer, with 74 out of every 100 patients succumbing to it within a year of diagnosis as it is often detected too late to be treated effectively. Now, that could change with the development of new tests that use dyes to detect the possibility of malignancy in fluid extracted from pancreatic cysts. When appropriately evaluated, these cysts can provide a means of detecting pancreatic cancer at an earlier stage. More...17 Mar 2023
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
In Other News
Novel Lymph Liquid Biopsy Could Transform Approach for Identifying Cancer Recurrence Risk
First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis Uses Only One Swab
Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment
High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women
‘Glow-In-The-Dark’ Proteins to Help Diagnose Viral Diseases More Quickly and Easily
Novel Test to Ensure Essential Treatment for Newborns with Serious Genetic Disease
Affordable Blood-Based Test Provides Early Detection of Colorectal Cancer
Novel Non-Sputum Based Technology Quickly and Easily Detects Active TB
Rapid PCR Diagnostic Test for STIs Provides Accurate Results in Less than 30 Minutes at POC
Urine-Based Molecular Test Detects Bladder Cancer Quickly and Accurately
Urine Gene Test Could Detect Bladder Cancer Years Before Symptoms Arise
Simple Blood Test Could Make It Easier to Diagnose Epilepsy
New AI Blood Test Could Become Game Changer for Bowel Cancer Diagnosis
Blood Test Detects Alzheimer's with 97% Accuracy 10 Years Before Symptoms Emerge
Blood Test Identifies Acute Myeloid Leukemia Patients Having Higher Relapse Risk
First Commercially Available Lab-Based Blood Test to Help Evaluate Concussion
ApoB Protein Testing More Accurately Predicts Heart Disease Risk than Testing for Cholesterol Alone
Awareness Announces Major Upgrades to Stat Fax 4700 ELISA Strip Reader
Single Blood Test Detects Various Tumor Types Less Invasively Than Tissue Biopsy
Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy
New Method to Detect RNA Viruses More Effective and Faster than PCR Test
Revolutionary Blood Test Enables Early Detection of Coronary Heart Disease
New Device That Detects Cancer Cells Could Help Avoid Invasive Biopsy Surgeries
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
